Cargando…

Deprescription in Advanced Cancer Patients

The use of multiple drugs is often referred to as polypharmacy, although this term has not been precisely defined. Frequently, drugs are used unwisely in multiple combinations increasing the risk of adverse reactions, or for the long-term prevention of diseases in patients with a short life expectan...

Descripción completa

Detalles Bibliográficos
Autor principal: Gonçalves, Ferraz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164016/
https://www.ncbi.nlm.nih.gov/pubmed/30134513
http://dx.doi.org/10.3390/pharmacy6030088
_version_ 1783359499757682688
author Gonçalves, Ferraz
author_facet Gonçalves, Ferraz
author_sort Gonçalves, Ferraz
collection PubMed
description The use of multiple drugs is often referred to as polypharmacy, although this term has not been precisely defined. Frequently, drugs are used unwisely in multiple combinations increasing the risk of adverse reactions, or for the long-term prevention of diseases in patients with a short life expectancy who, therefore, will not benefit from them. The reflection on this has led to the introduction of the concept of deprescription. There are many reasons for the inappropriate drug prescription and barriers to reduce medications. Tools were developed to help prescribers to limit the number of prescribed drugs that patients are taking. Several studies have shown that deprescription of some drugs is possible and safe and can even have a positive influence on wellbeing, cognitive function, falls, and admission to a hospital. Deprescription should be individualized and carried out, as far as possible, in agreement with patients and their families. A six-step method for deprescription is proposed.
format Online
Article
Text
id pubmed-6164016
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61640162018-10-10 Deprescription in Advanced Cancer Patients Gonçalves, Ferraz Pharmacy (Basel) Review The use of multiple drugs is often referred to as polypharmacy, although this term has not been precisely defined. Frequently, drugs are used unwisely in multiple combinations increasing the risk of adverse reactions, or for the long-term prevention of diseases in patients with a short life expectancy who, therefore, will not benefit from them. The reflection on this has led to the introduction of the concept of deprescription. There are many reasons for the inappropriate drug prescription and barriers to reduce medications. Tools were developed to help prescribers to limit the number of prescribed drugs that patients are taking. Several studies have shown that deprescription of some drugs is possible and safe and can even have a positive influence on wellbeing, cognitive function, falls, and admission to a hospital. Deprescription should be individualized and carried out, as far as possible, in agreement with patients and their families. A six-step method for deprescription is proposed. MDPI 2018-08-21 /pmc/articles/PMC6164016/ /pubmed/30134513 http://dx.doi.org/10.3390/pharmacy6030088 Text en © 2018 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gonçalves, Ferraz
Deprescription in Advanced Cancer Patients
title Deprescription in Advanced Cancer Patients
title_full Deprescription in Advanced Cancer Patients
title_fullStr Deprescription in Advanced Cancer Patients
title_full_unstemmed Deprescription in Advanced Cancer Patients
title_short Deprescription in Advanced Cancer Patients
title_sort deprescription in advanced cancer patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164016/
https://www.ncbi.nlm.nih.gov/pubmed/30134513
http://dx.doi.org/10.3390/pharmacy6030088
work_keys_str_mv AT goncalvesferraz deprescriptioninadvancedcancerpatients